Ann: Encouraging Initial Data from CYP-006TK DFU Trial, page-23

Ha, ha,

He really did declare he sold out too:



Oh dear. Clearly a guy who doesn't mind ignoring the disclosure fine print (on his holdings) when he posts. The self declared "day trader" will tell us he bought it back lower subsequently of course. He just forgot to tell all - yet funny how he tells all how he sold the higher and bought lower always after the event....

Oh Sector, you sure did leave us with some detritus on these threads - but thanks for the cheap stock at least. Meanwhile CYP at at $50 million mkt cap remains a significantly under-valued stock for its IP, balance sheet and funded trials. Sumitomo thought so, considerably higher, when its regulatory pathways far less advanced.